Palatin Technologies
PTN
$1.82
Share price
5.81%
Change (1 day)
-22.88%
Change (1 year)
Categories
Palatin Technologies (PTN) - P/B ratio
P/B ratio as of April 2024 : -2.57
According to Palatin Technologies's latest financial reports the company has a price-to-book ratio of -2.57.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Palatin Technologies - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -4.80 | -396.12% |
| 2022-12-31 | 1.62 | -51.77% |
| 2021-12-31 | 3.36 | 46.74% |
| 2020-12-31 | 2.29 | 16.81% |
| 2019-12-31 | 1.96 | -71.17% |
| 2018-12-31 | 6.80 | -59.93% |
| 2017-12-31 | 17.0 | -502.09% |
| 2016-12-31 | -4.22 | -169.89% |
| 2015-12-31 | 6.04 | 551.12% |
| 2014-12-31 | 0.9281 | -50.76% |
| 2013-12-31 | 1.88 | 153.81% |
| 2012-12-31 | 0.7426 | -32.95% |
| 2011-12-31 | 1.11 | -72.1% |
| 2010-12-31 | 3.97 | 24.22% |
| 2009-12-31 | 3.20 | 10.72% |
| 2008-12-31 | 2.89 | 165.99% |
| 2007-12-31 | 1.09 | -96.43% |
| 2006-12-31 | 30.4 | 6.98% |
| 2005-12-31 | 28.4 | 250.12% |
| 2004-12-31 | 8.11 | -9.07% |
| 2003-12-31 | 8.91 | 100.72% |
| 2002-12-31 | 4.44 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | -299.03% | 🇺🇸 USA |
 AstraZeneca AZN | 5.95 | -331.30% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | 6.12 | -338.06% | 🇺🇸 USA |
 MediciNova MNOV | 1.03 | -140.04% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 1.79 | -169.42% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 3.00 | -216.46% | 🇺🇸 USA |
 GlycoMimetics
GLYC | 2.26 | -187.94% | 🇺🇸 USA |
 Ardelyx ARDX | 8.97 | -448.63% | 🇺🇸 USA |